0001437749-23-013010.txt : 20230508 0001437749-23-013010.hdr.sgml : 20230508 20230508160214 ACCESSION NUMBER: 0001437749-23-013010 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230502 FILED AS OF DATE: 20230508 DATE AS OF CHANGE: 20230508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CONKLING WILLIAM CENTRAL INDEX KEY: 0001852018 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39780 FILM NUMBER: 23897622 MAIL ADDRESS: STREET 1: C/O RAFAEL HOLDINGS, INC. STREET 2: 520 BROAD ST CITY: NEWARK STATE: NJ ZIP: 07102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc. CENTRAL INDEX KEY: 0000922247 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 593029743 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6714 NW 16TH STREET, SUITE B CITY: GAINESVILLE STATE: FL ZIP: 32653 BUSINESS PHONE: 386-418-8060 MAIL ADDRESS: STREET 1: PO BOX 1180 CITY: ALACHUA STATE: FL ZIP: 32616-1180 FORMER COMPANY: FORMER CONFORMED NAME: CTD HOLDINGS INC DATE OF NAME CHANGE: 20000913 FORMER COMPANY: FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC DATE OF NAME CHANGE: 19941012 3 1 rdgdoc.xml FORM 3 X0206 3 2023-05-02 0 0000922247 Cyclo Therapeutics, Inc. CYTH 0001852018 CONKLING WILLIAM 6714 NW 16TH STREET SUITE B GAINESVILLE FL 32653 1 Common Stock 0 I See Footnote The reporting person is the Chief Executive Officer of Rafael Holdings, Inc., which holds 2,514,970 shares of common stock of the Issuer and a warrant to purchase an additional 2,514,970 shares of common stock of the Issuer. The reporting person disclaims beneficial ownership of the securities of the Issuer held by Rafael Holdings, Inc. /s/ William Conkling 2023-05-08